RAGE and glyoxalase in kidney disease (Q38857649)

7 September 2017

1 reference

title

RAGE and glyoxalase in kidney disease (English)

1 reference

7 September 2017

Reiko Inagi

1

1 reference

7 September 2017

6 June 2016

1 reference

7 September 2017

Glycoconjugate Journal

1 reference

7 September 2017

33

1 reference

7 September 2017

619-626

1 reference

7 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s10719-016-9689-8

7 September 2017

0 references

cites work

RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Molecular aspects of renal senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Receptor for advanced glycation endproducts and progressive kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Targeting of receptor for advanced glycation end products suppresses cyst growth in polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Soluble receptor for advanced glycation end products inhibits disease progression in autosomal dominant polycystic kidney disease by down-regulating cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Lycopene supplementation reduces TNF-α via RAGE in the kidney of obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

The axis AGE-RAGE-soluble RAGE and oxidative stress in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Uremic Toxicity of Advanced Glycation End Products in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Glyoxalase I reduces glycative and oxidative stress and prevents age-related endothelial dysfunction through modulation of endothelial nitric oxide synthase phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Possible role of methylglyoxal and glyoxalase in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Role of the glyoxalase system in astrocyte-mediated neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

The role of glyoxalase system in renal hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Glycative stress and glyoxalase in kidney disease and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Glyoxalase I retards renal senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

daf-16/FOXO and glod-4/glyoxalase-1 are required for the life-prolonging effect of human insulin under high glucose conditions in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/- mice with or without diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Dicarbonyl stress in the absence of hyperglycemia increases endothelial inflammation and atherogenesis similar to that observed in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Proteostasis in endoplasmic reticulum--new mechanisms in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Endoplasmic reticulum stress as a progression factor for kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Impact of ER stress-regulated ATF4/p16 signaling on the premature senescence of renal tubular epithelial cells in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Endoplasmic reticulum stress signal impairs erythropoietin production: a role for ATF4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Advanced oxidation protein products induce apoptosis in podocytes through induction of endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Stress in the kidney is the road to pERdition: is endoplasmic reticulum stress a pathogenic mediator of diabetic nephropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Intracellular accumulation of advanced glycation end products induces apoptosis via endoplasmic reticulum stress in chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Inhibitors of advanced glycation and endoplasmic reticulum stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Pathophysiological importance of aggregated damaged proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Chromatin decondensation and T cell hyperresponsiveness in diabetes-associated hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Role of epigenetic mechanisms in the vascular complications of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Peroxynitrite-mediated glyoxalase I epigenetic inhibition drives apoptosis in airway epithelial cells exposed to crystalline silica via a novel mechanism involving argpyrimidine-modified Hsp70, JNK, and NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10719-016-9689-8

Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria

21 January 2018

1 reference

12 December 2020

Aging-Dependent Reduction in Glyoxalase 1 Delays Wound Healing

1 reference

12 December 2020

Impairment of the proteasome is crucial for glucose-induced lifespan reduction in the mev-1 mutant of Caenorhabditis elegans

1 reference

12 December 2020

Exploring glyoxalase 1 expression in prostate cancer tissues: targeting the enzyme by ethyl pyruvate defangs some malignancy-associated properties

1 reference

12 December 2020

10.1007/S10719-016-9689-8

Identifiers

DOI

1 reference

PubMed ID

27270765

Dimensions Publication ID

7 September 2017

0 references

1 reference

PubMed ID

27270765